Cellyan Biotechnology Co., Ltd SEC filings HKPD
Cellyan Biotechnology Co., Ltd has 67 filings in SEC EDGAR's recent list, going back to Mar 29, 2024. Its latest annual report, Form 20-F, was filed on Aug 7, 2026 for the period ended Mar 31, 2026. The most recent current report (Form 6-K) was filed on Oct 21, 2026. The company's fiscal year ends on March 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Oct 21, 2026 | Oct 21, 2026 |
| 6-K | Current report (foreign issuer) | Sep 24, 2026 | Sep 23, 2026 |
| 6-K | Current report (foreign issuer) | Sep 23, 2026 | Sep 23, 2026 |
| 6-K | Current report (foreign issuer) | Sep 10, 2026 | Sep 9, 2026 |
| S-8 | Employee stock plan registration | Aug 13, 2026 | — |
| 20-F | Annual report (foreign issuer) | Aug 7, 2026 | Mar 31, 2026 |
| NT 20-F | Notification of late filing | Jul 31, 2026 | Mar 31, 2026 |
| 6-K | Current report (foreign issuer) | Jul 16, 2026 | Jul 16, 2026 |
| EFFECT | Filing | Jun 24, 2026 | — |
| F-3 | Shelf registration (foreign issuer) | Jun 12, 2026 | — |
| EFFECT | Filing | Apr 8, 2026 | — |
| CORRESP | Letter to the SEC | Apr 6, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 2, 2026 | — |
| F-1 | Registration statement (foreign issuer) | Mar 27, 2026 | — |
| 6-K | Current report (foreign issuer) | Mar 27, 2026 | Mar 26, 2026 |
| 6-K | Current report (foreign issuer) | Mar 18, 2026 | Sep 30, 2025 |
| 6-K | Current report (foreign issuer) | Jan 16, 2026 | Jan 16, 2026 |
| 6-K | Current report (foreign issuer) | Dec 31, 2025 | Dec 30, 2025 |
| 6-K | Current report (foreign issuer) | Dec 17, 2025 | Dec 17, 2025 |
| 6-K | Current report (foreign issuer) | Nov 24, 2025 | Nov 24, 2025 |
| 6-K | Current report (foreign issuer) | Nov 12, 2025 | Nov 12, 2025 |
| 6-K | Current report (foreign issuer) | Oct 7, 2025 | Oct 6, 2025 |
| 6-K | Current report (foreign issuer) | Sep 11, 2025 | Sep 11, 2025 |
| 20-F | Annual report (foreign issuer) | Aug 14, 2025 | Mar 31, 2025 |
| NT 20-F | Notification of late filing | Jul 31, 2025 | Mar 31, 2025 |
| 6-K | Current report (foreign issuer) | Mar 28, 2025 | Mar 28, 2025 |
| 6-K | Current report (foreign issuer) | Jan 17, 2025 | Jan 17, 2025 |
| 424B4 | Prospectus | Jan 15, 2025 | — |
| CERT | Filing | Jan 13, 2025 | — |
| 8-A12B | For registration of certain classes | Jan 8, 2025 | — |
| EFFECT | Filing | Dec 20, 2024 | — |
| CORRESP | Letter to the SEC | Dec 20, 2024 | — |
| CORRESP | Letter to the SEC | Dec 20, 2024 | — |
| CORRESP | Letter to the SEC | Dec 10, 2024 | — |
| F-1/A | Amendment no. 3 to form f-1 | Dec 10, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 3, 2024 | — |
| F-1/A | Amendment no. 2 to form f-1 | Nov 27, 2024 | — |
| FWP | Free writing prospectus | Nov 22, 2024 | — |
| F-1/A | Amendment no. 1 to form f-1 | Nov 21, 2024 | — |
| CORRESP | Letter to the SEC | Nov 20, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 8, 2024 | — |
| F-1 | Registration statement (foreign issuer) | Oct 29, 2024 | — |
| DRSLTR | Filing | Oct 4, 2024 | — |
| DRS/A | Filing | Oct 4, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 30, 2024 | — |
| DRSLTR | Filing | Sep 23, 2024 | — |
| DRS/A | Filing | Sep 23, 2024 | — |
| UPLOAD | Letter from the SEC | Sep 3, 2024 | — |
| DRS/A | Filing | Aug 22, 2024 | — |
| DRSLTR | Filing | Jun 28, 2024 | — |
| DRS/A | Filing | Jun 28, 2024 | — |
| UPLOAD | Letter from the SEC | Jun 6, 2024 | — |
| DRSLTR | Filing | May 14, 2024 | — |
| DRS/A | Filing | May 14, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 26, 2024 | — |
| DRS | Filing | Mar 29, 2024 | — |
Showing 56 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Listed as
- HKPD (Nasdaq)
- Fiscal year ends
- March 31
- Incorporated in
- Cayman Islands
- Headquarters
- Kowloon
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 2007702
- Former names
- Hong Kong Pharma Digital Technology Holdings Ltd (until Dec 17, 2025)
Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- Mckesson Corp MCK
- Cencora, Inc. COR
- Cardinal Health Inc CAH
- Herbalife Ltd. HLF
- Nu Skin Enterprises, Inc. NUS
- EnerSyn Global Inc. ESYN
- Cosmos Health Inc. COSM
- DataMeds AI, Inc. MEDS
All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.